Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
Regnery S, Adeberg S, Dreher C, Oberhollenzer J, Meissner JE, Goerke S, Windschuh J, Deike-Hofmann K, Bickelhaupt S, Zaiss M, Radbruch A, Bendszus M, Wick W, Unterberg A, Rieken S, Debus J, Bachert P, Ladd M, Schlemmer HP, Paech D.
Regnery S, et al.
Oncotarget. 2018 Jun 19;9(47):28772-28783. doi: 10.18632/oncotarget.25594. eCollection 2018 Jun 19.
Oncotarget. 2018.
PMID: 29983895
Free PMC article.